Nektar Therapeutics (NKTR)
USD 0.75
(-3.6%)
USD 0.75
(-3.6%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 53.47 Million USD | -24.06% |
| 2022 | 70.42 Million USD | -8.56% |
| 2021 | 77.01 Million USD | -42.29% |
| 2020 | 133.43 Million USD | 43.11% |
| 2019 | 93.24 Million USD | -92.02% |
| 2018 | 1.16 Billion USD | 321.74% |
| 2017 | 277.16 Million USD | 104.97% |
| 2016 | 135.22 Million USD | -31.25% |
| 2015 | 196.68 Million USD | 14.23% |
| 2014 | 172.17 Million USD | 55.94% |
| 2013 | 110.41 Million USD | 117.5% |
| 2012 | 50.76 Million USD | 2.37% |
| 2011 | 49.58 Million USD | -62.82% |
| 2010 | 133.37 Million USD | 225.43% |
| 2009 | 40.98 Million USD | -25.69% |
| 2008 | 55.14 Million USD | -56.06% |
| 2007 | 125.51 Million USD | 25.98% |
| 2006 | 99.62 Million USD | 10.35% |
| 2005 | 90.28 Million USD | -4.43% |
| 2004 | 94.47 Million USD | 3.16% |
| 2003 | 91.57 Million USD | 4.27% |
| 2002 | 87.82 Million USD | 19.82% |
| 2001 | 73.29 Million USD | 41.97% |
| 2000 | 51.62 Million USD | 24.83% |
| 1999 | 41.35 Million USD | 89.76% |
| 1998 | 21.79 Million USD | 34.13% |
| 1997 | 16.24 Million USD | 100.6% |
| 1996 | 8.1 Million USD | 80.0% |
| 1995 | 4.5 Million USD | 104.55% |
| 1994 | 2.2 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 13.74 Million USD | 4.91% |
| 2024 Q1 | 13.1 Million USD | -21.06% |
| 2023 Q4 | 16.6 Million USD | 41.74% |
| 2023 Q3 | 11.71 Million USD | -13.27% |
| 2023 Q2 | 13.5 Million USD | -7.08% |
| 2023 FY | 53.47 Million USD | -24.06% |
| 2023 Q1 | 14.53 Million USD | -7.95% |
| 2022 FY | 70.42 Million USD | -8.56% |
| 2022 Q4 | 15.79 Million USD | -15.35% |
| 2022 Q3 | 18.65 Million USD | 13.25% |
| 2022 Q2 | 16.47 Million USD | -15.57% |
| 2022 Q1 | 19.5 Million USD | 3.51% |
| 2021 FY | 77.01 Million USD | -42.29% |
| 2021 Q2 | 20.66 Million USD | 15.49% |
| 2021 Q3 | 19.61 Million USD | -5.1% |
| 2021 Q4 | 18.84 Million USD | -3.9% |
| 2021 Q1 | 17.89 Million USD | -6.52% |
| 2020 Q1 | 46.76 Million USD | 67.77% |
| 2020 Q3 | 24.46 Million USD | -43.21% |
| 2020 Q2 | 43.07 Million USD | -7.89% |
| 2020 Q4 | 19.13 Million USD | -21.76% |
| 2020 FY | 133.43 Million USD | 43.11% |
| 2019 Q1 | 22.78 Million USD | -29.61% |
| 2019 Q2 | 18.29 Million USD | -19.69% |
| 2019 Q3 | 24.29 Million USD | 32.76% |
| 2019 Q4 | 27.87 Million USD | 14.75% |
| 2019 FY | 93.24 Million USD | -92.02% |
| 2018 Q1 | 31.37 Million USD | -63.4% |
| 2018 Q3 | 22.97 Million USD | -97.88% |
| 2018 Q2 | 1.08 Billion USD | 3349.56% |
| 2018 Q4 | 32.36 Million USD | 40.85% |
| 2018 FY | 1.16 Billion USD | 321.74% |
| 2017 Q1 | 18.59 Million USD | -39.71% |
| 2017 Q3 | 147.25 Million USD | 475.21% |
| 2017 Q4 | 85.71 Million USD | -41.79% |
| 2017 FY | 277.16 Million USD | 104.97% |
| 2017 Q2 | 25.6 Million USD | 37.66% |
| 2016 Q1 | 50.01 Million USD | 61.3% |
| 2016 Q3 | 29.3 Million USD | 16.93% |
| 2016 Q4 | 30.84 Million USD | 5.27% |
| 2016 FY | 135.22 Million USD | -31.25% |
| 2016 Q2 | 25.06 Million USD | -49.89% |
| 2015 Q4 | 31 Million USD | -41.71% |
| 2015 Q2 | 12.12 Million USD | -87.92% |
| 2015 FY | 196.68 Million USD | 14.23% |
| 2015 Q3 | 53.19 Million USD | 338.62% |
| 2015 Q1 | 100.35 Million USD | 657.24% |
| 2014 Q1 | 11.86 Million USD | -46.52% |
| 2014 FY | 172.17 Million USD | 55.94% |
| 2014 Q2 | 23.4 Million USD | 97.28% |
| 2014 Q3 | 123.65 Million USD | 428.31% |
| 2014 Q4 | 13.25 Million USD | -89.28% |
| 2013 Q4 | 22.18 Million USD | -53.81% |
| 2013 Q2 | 28.85 Million USD | 154.35% |
| 2013 FY | 110.41 Million USD | 117.5% |
| 2013 Q1 | 11.34 Million USD | -18.14% |
| 2013 Q3 | 48.03 Million USD | 66.48% |
| 2012 Q1 | 9.24 Million USD | -10.55% |
| 2012 FY | 50.76 Million USD | 2.37% |
| 2012 Q4 | 13.85 Million USD | 23.89% |
| 2012 Q3 | 11.18 Million USD | -32.14% |
| 2012 Q2 | 16.48 Million USD | 78.33% |
| 2011 Q3 | 22.03 Million USD | 139.69% |
| 2011 Q2 | 9.19 Million USD | 14.37% |
| 2011 Q4 | 10.33 Million USD | -53.1% |
| 2011 FY | 49.58 Million USD | -62.82% |
| 2011 Q1 | 8.03 Million USD | -77.09% |
| 2010 Q2 | 37.67 Million USD | 30.18% |
| 2010 FY | 133.37 Million USD | 225.43% |
| 2010 Q4 | 35.07 Million USD | 10.72% |
| 2010 Q3 | 31.68 Million USD | -15.91% |
| 2010 Q1 | 28.94 Million USD | -0.48% |
| 2009 Q3 | 4.53 Million USD | 64.38% |
| 2009 Q1 | 4.61 Million USD | -74.6% |
| 2009 FY | 40.98 Million USD | -25.69% |
| 2009 Q4 | 29.08 Million USD | 541.7% |
| 2009 Q2 | 2.75 Million USD | -40.22% |
| 2008 Q1 | 7.43 Million USD | -82.19% |
| 2008 Q3 | 16.09 Million USD | 19.45% |
| 2008 Q4 | 18.15 Million USD | 12.85% |
| 2008 FY | 55.14 Million USD | -56.06% |
| 2008 Q2 | 13.47 Million USD | 81.29% |
| 2007 Q1 | 28.49 Million USD | -0.93% |
| 2007 Q3 | 28.86 Million USD | 9.22% |
| 2007 FY | 125.51 Million USD | 25.98% |
| 2007 Q2 | 26.42 Million USD | -7.25% |
| 2007 Q4 | 41.72 Million USD | 44.56% |
| 2006 FY | 99.62 Million USD | 10.35% |
| 2006 Q4 | 28.76 Million USD | 4.77% |
| 2006 Q3 | 27.45 Million USD | 17.07% |
| 2006 Q2 | 23.45 Million USD | 17.46% |
| 2006 Q1 | 19.96 Million USD | -8.14% |
| 2005 Q1 | 23.23 Million USD | -8.2% |
| 2005 Q2 | 20.45 Million USD | -12.0% |
| 2005 Q3 | 27.15 Million USD | 32.78% |
| 2005 Q4 | 21.73 Million USD | -19.96% |
| 2005 FY | 90.28 Million USD | -4.43% |
| 2004 Q2 | 21.79 Million USD | -6.44% |
| 2004 Q3 | 24.06 Million USD | 10.44% |
| 2004 Q4 | 25.31 Million USD | 5.17% |
| 2004 FY | 94.47 Million USD | 3.16% |
| 2004 Q1 | 23.29 Million USD | 2.09% |
| 2003 Q3 | 23.81 Million USD | -0.93% |
| 2003 FY | 91.57 Million USD | 4.27% |
| 2003 Q4 | 22.81 Million USD | -4.19% |
| 2003 Q2 | 24.04 Million USD | 14.99% |
| 2003 Q1 | 20.9 Million USD | -0.98% |
| 2002 Q3 | 21.27 Million USD | 3.4% |
| 2002 Q2 | 20.57 Million USD | -17.21% |
| 2002 FY | 87.82 Million USD | 19.82% |
| 2002 Q1 | 24.85 Million USD | 13.1% |
| 2002 Q4 | 21.11 Million USD | -0.78% |
| 2001 Q4 | 21.97 Million USD | 7.59% |
| 2001 Q3 | 20.42 Million USD | 21.59% |
| 2001 FY | 73.29 Million USD | 41.97% |
| 2001 Q2 | 16.79 Million USD | 19.17% |
| 2001 Q1 | 14.09 Million USD | 7.23% |
| 2000 Q4 | 13.14 Million USD | -6.51% |
| 2000 Q2 | 13.78 Million USD | 29.68% |
| 2000 Q1 | 10.63 Million USD | -18.66% |
| 2000 FY | 51.62 Million USD | 24.83% |
| 2000 Q3 | 14.06 Million USD | 1.97% |
| 1999 FY | 41.35 Million USD | 89.76% |
| 1999 Q2 | 9.87 Million USD | 26.95% |
| 1999 Q1 | 7.78 Million USD | 22.17% |
| 1999 Q4 | 13.07 Million USD | 23.01% |
| 1999 Q3 | 10.62 Million USD | 7.6% |
| 1998 FY | 21.79 Million USD | 34.13% |
| 1998 Q4 | 6.36 Million USD | 30.41% |
| 1998 Q3 | 4.88 Million USD | -26.89% |
| 1998 Q2 | 6.67 Million USD | 72.81% |
| 1998 Q1 | 3.86 Million USD | -19.31% |
| 1997 Q1 | 3.17 Million USD | 44.41% |
| 1997 Q4 | 4.79 Million USD | 11.16% |
| 1997 Q3 | 4.3 Million USD | 8.46% |
| 1997 Q2 | 3.97 Million USD | 25.06% |
| 1997 FY | 16.24 Million USD | 100.6% |
| 1996 Q2 | 1.4 Million USD | -6.67% |
| 1996 Q3 | 1.8 Million USD | 28.57% |
| 1996 Q4 | 2.2 Million USD | 22.22% |
| 1996 FY | 8.1 Million USD | 80.0% |
| 1996 Q1 | 1.5 Million USD | 87.5% |
| 1995 Q1 | 600 Thousand USD | -85.37% |
| 1995 Q3 | 1 Million USD | 0.0% |
| 1995 Q4 | 800 Thousand USD | -20.0% |
| 1995 FY | 4.5 Million USD | 104.55% |
| 1995 Q2 | 1 Million USD | 66.67% |
| 1994 Q4 | 4.1 Million USD | 920.0% |
| 1994 FY | 2.2 Million USD | 0.0% |
| 1994 Q2 | -700 Thousand USD | -16.67% |
| 1994 Q1 | -600 Thousand USD | 0.0% |
| 1994 Q3 | -500 Thousand USD | 28.57% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 55231.959% |
| Psyence Biomedical Ltd. | -240.00 USD | 22282600.0% |
| XOMA Corporation | 3.86 Million USD | -1285.082% |
| Mesoblast Limited | -9.81 Million USD | 644.86% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 60.465% |
| Aptorum Group Limited | -1.11 Million USD | 4897.576% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 1189821.913% |
| HilleVax, Inc. | -2.15 Million USD | 2580.427% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 853.423% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 271.582% |
| Precision BioSciences, Inc. | 40.47 Million USD | -32.136% |
| Dyadic International, Inc. | 922.95 Thousand USD | -5694.203% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 36479.592% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 150.392% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -153.92% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -12512.736% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -29.218% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 43.543% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 715.61% |
| IGM Biosciences, Inc. | -211.66 Million USD | 125.266% |
| Opthea Limited | 21.72 Thousand USD | -246115.47% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -13202.985% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -2096.222% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -1666.7% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 55.343% |
| NextCure, Inc. | -3.68 Million USD | 1551.629% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 500.349% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 4538.45% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -166.697% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 65.451% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 154.449% |
| Senti Biosciences, Inc. | -2.68 Million USD | 2093.217% |
| Apollomics, Inc. | 127 Thousand USD | -42008.661% |
| PureTech Health plc | -1.6 Million USD | 3436.12% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 284.611% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -6568.08% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 148.401% |
| ChromaDex Corporation | 50.78 Million USD | -5.313% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 55.61% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 217.988% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 954.281% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 154.479% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -44465.0% |
| Fortress Biotech, Inc. | 57.85 Million USD | 7.562% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 223.043% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 232613.043% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -41036.923% |
| Celcuity Inc. | -142.77 Thousand USD | 37556.924% |
| ContextLogic Inc. | 59 Million USD | 9.359% |
| GH Research PLC | -315 Thousand USD | 17077.143% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -222.604% |
| Cassava Sciences, Inc. | -89.42 Million USD | 159.803% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -13647.558% |
| ImmuCell Corporation | 4.39 Million USD | -1116.436% |
| Amarin Corporation plc | 165.54 Million USD | 67.695% |
| TG Therapeutics, Inc. | 219.1 Million USD | 75.593% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 2779.259% |
| Acelyrin, Inc. | -115 Thousand USD | 46602.609% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 7.02 Million USD | -661.036% |
| Novavax, Inc. | 639.93 Million USD | 91.643% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -10284.078% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 98.426% |
| AnaptysBio, Inc. | 14.78 Million USD | -261.802% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 9531.746% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 4354.415% |
| AbCellera Biologics Inc. | 38.02 Million USD | -40.639% |
| CorMedix Inc. | -205.56 Thousand USD | 26115.509% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -118.715% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 852.612% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.527% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 11369.321% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 514311.538% |
| Soligenix, Inc. | 97.31 Thousand USD | -54855.76% |
| Century Therapeutics, Inc. | -10.8 Million USD | 594.754% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 77.786% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 10448.992% |
| Kura Oncology, Inc. | -849 Thousand USD | 6398.94% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 1605.998% |
| Ardelyx, Inc. | 106.66 Million USD | 49.862% |
| Ainos, Inc. | -253.73 Thousand USD | 21176.486% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 179.694% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| Prothena Corporation plc | -129.2 Million USD | 141.391% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 46.003% |
| Autolus Therapeutics plc | -4.86 Million USD | 1198.788% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -6.057% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 31932.143% |
| Celularity Inc. | 6.75 Million USD | -691.68% |
| Rallybio Corporation | -150 Thousand USD | 35752.0% |
| GRI Bio, Inc. | 10.84 Million USD | -393.294% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -2005.445% |
| Omeros Corporation | -69.77 Million USD | 176.639% |
| INmune Bio, Inc. | 155 Thousand USD | -34401.935% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 13.66% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 3650.31% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 8347.0% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 182780.877% |
| Humacyte, Inc. | -76.55 Million USD | 169.86% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 17185.623% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 43.386% |
| Immunocore Holdings plc | 248.39 Million USD | 78.47% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 452.548% |
| Verastem, Inc. | -62 Thousand USD | 86354.839% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 20589.655% |
| Histogen Inc. | 3.76 Million USD | -1318.891% |
| Surrozen, Inc. | -27.23 Million USD | 296.394% |
| Blueprint Medicines Corporation | 236.58 Million USD | 77.396% |
| Organovo Holdings, Inc. | -5.38 Million USD | 1092.355% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | -756 Thousand USD | 7173.81% |
| MEI Pharma, Inc. | 49.32 Million USD | -8.415% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -781.541% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 79762.153% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 3850.21% |
| Summit Therapeutics Inc. | -2.05 Million USD | 2708.683% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 1214.589% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -84.058% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -36579.012% |
| Turnstone Biologics Corp. | 16.5 Million USD | -223.991% |
| Pulmatrix, Inc. | -8.22 Million USD | 750.584% |
| Synaptogenix, Inc. | -6347.00 USD | 842671.294% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 104958.824% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 66.859% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 13503.008% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 113.41% |
| Cytokinetics, Incorporated | -322.59 Million USD | 116.578% |
| Exelixis, Inc. | 1.75 Billion USD | 96.957% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 147.68% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 84.182% |
| Evogene Ltd. | 1.39 Million USD | -3722.588% |
| Replimune Group, Inc. | -2.65 Million USD | 2114.237% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 93387.514% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 4926.534% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 45232.542% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 1.1 Million USD | -4726.534% |
| Avid Bioservices, Inc. | 7.31 Million USD | -630.773% |
| Insmed Incorporated | 239.63 Million USD | 77.684% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -10681.855% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 3950.108% |
| Sagimet Biosciences Inc. | 2 Million USD | -2573.9% |
| MediWound Ltd. | 3.57 Million USD | -1394.634% |
| MiMedx Group, Inc. | 266.84 Million USD | 79.959% |
| OmniAb, Inc. | 14.66 Million USD | -264.614% |
| Alector, Inc. | -95.05 Million USD | 156.261% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 57.429% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 93.87% |
| Mereo BioPharma Group plc | 7.42 Million USD | -620.145% |
| Zai Lab Limited | 170.9 Million USD | 68.709% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 34.685% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 445750.0% |
| Aura Biosciences, Inc. | -1.29 Million USD | 4229.575% |
| Immunic, Inc. | -111 Thousand USD | 48278.378% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 2273.019% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -237.316% |
| Veracyte, Inc. | 248.14 Million USD | 78.449% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 100.765% |
| FibroGen, Inc. | 128.9 Million USD | 58.513% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Allakos Inc. | -6.14 Million USD | 970.835% |
| scPharmaceuticals Inc. | 9.78 Million USD | -446.698% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 177.509% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 88.763% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 9482014.894% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 468876.297% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 558.374% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 84.95% |
| Precigen, Inc. | 106 Thousand USD | -50350.943% |
| Fortrea Holdings Inc. | 424 Million USD | 87.387% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 162.063% |
| Incyte Corporation | 3.44 Billion USD | 98.446% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 105496.137% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -261.484% |
| XBiotech Inc. | -1.74 Million USD | 3166.399% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -329.197% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 4926.534% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 240.95 Million USD | 77.806% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 184506.897% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 215.078% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 170.8% |
| Agenus Inc. | 139.61 Million USD | 61.696% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 1427.974% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 27.145% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -218.265% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 86.254% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 207.716% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -27365.744% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 83.633% |
| UroGen Pharma Ltd. | 73.35 Million USD | 27.094% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 572.26% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 300.337% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -990233.333% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 28395.238% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 80124.541% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -1220.118% |
| Chimerix, Inc. | 324 Thousand USD | -16405.556% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 10286.286% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 121123.807% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 24300.709% |
| Pluri Inc. | 322 Thousand USD | -16508.075% |
| Cue Biopharma, Inc. | -32.6 Million USD | 264.008% |
| MeiraGTx Holdings plc | 287 Thousand USD | -18533.449% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -9181.491% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 2701009.091% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 14.273% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 611.998% |
| CalciMedica, Inc. | -58 Thousand USD | 92303.448% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 1980.38% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 273.264% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 4670.769% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 468876.297% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -1826.729% |
| Nutriband Inc. | 862.1 Thousand USD | -6103.189% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 15782.698% |
| Vor Biopharma Inc. | -3.49 Million USD | 1631.443% |
| Roivant Sciences Ltd. | 109.23 Million USD | 51.043% |
| ProKidney Corp. | -3.16 Million USD | 1787.536% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 221.784% |
| Daré Bioscience, Inc. | 2.76 Million USD | -1830.947% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -679.904% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 3193.002% |
| Bicycle Therapeutics plc | -129.52 Million USD | 141.289% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 167.977% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 162154.545% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 113.381% |
| Atai Life Sciences N.V. | -5000.00 USD | 1069660.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 43985.146% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 55806.25% |
| MediciNova, Inc. | 979.7 Thousand USD | -5358.582% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 163.423% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 56657.559% |
| GeoVax Labs, Inc. | -20.72 Million USD | 358.089% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 5.663% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 78.131% |
| Biomea Fusion, Inc. | -4.2 Million USD | 1372.983% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | -3.73 Million USD | 1532.958% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 17350.968% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1069660.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 170.022% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 74.979% |
| bluebird bio, Inc. | -4.03 Million USD | 1426.998% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 5783.103% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -5200.099% |
| Imunon, Inc. | -720 Thousand USD | 7527.448% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 97.192% |
| BioAtla, Inc. | -103.73 Million USD | 151.555% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 122.024% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 17295.498% |
| DBV Technologies S.A. | 15.72 Million USD | -240.018% |
| Fortress Biotech, Inc. | 57.85 Million USD | 7.562% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 129.479% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 176.304% |
| aTyr Pharma, Inc. | -2.38 Million USD | 2339.447% |
| Viridian Therapeutics, Inc. | -1 Million USD | 5405.357% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -411369130.769% |
| Galecto, Inc. | -830 Thousand USD | 6543.133% |
| Akari Therapeutics, Plc | -4000.00 USD | 1337050.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 91.603% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -4679.088% |
| Entera Bio Ltd. | -56 Thousand USD | 95596.429% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 60.028% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 9465.674% |
| Xencor, Inc. | -85.26 Million USD | 162.723% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -1977.622% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 235.928% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 5441.198% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 69.93% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -27365.744% |
| Portage Biotech Inc. | -54 Thousand USD | 99133.333% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 56657.559% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 14285.146% |
| OncoCyte Corporation | 413 Thousand USD | -12848.668% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 24089289.189% |
| Purple Biotech Ltd. | -196 Thousand USD | 27384.694% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -496.32% |
| Onconetix, Inc. | -1.12 Million USD | 4844.47% |
| MacroGenics, Inc. | 50.52 Million USD | -5.84% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 356524.953% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 8105.689% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -180.828% |
| Prime Medicine, Inc. | -147.9 Million USD | 136.157% |
| Aditxt, Inc. | -111.66 Thousand USD | 47993.606% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 712554.837% |
| Savara Inc. | -44.26 Million USD | 220.821% |
| Curis, Inc. | 9.81 Million USD | -445.082% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 42955.082% |
| Adagene Inc. | 18.11 Million USD | -195.271% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 23555.263% |
| BeiGene, Ltd. | 2.07 Billion USD | 97.428% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -8681.281% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 37418.651% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 61.856% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 189617.329% |
| SciSparc Ltd. | 2.19 Million USD | -2335.246% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 189617.329% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 5944.59% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 213593.553% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 172709.903% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -567.974% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 2.089% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 10077.239% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 96.477% |
| ADMA Biologics, Inc. | 88.21 Million USD | 39.38% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 51.283% |
| Clene Inc. | 533 Thousand USD | -9933.396% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 148.123% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 1590.468% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 5688.088% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -2590.04% |
| Adicet Bio, Inc. | -6.09 Million USD | 976.976% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -7.375% |
| Absci Corporation | -41.84 Million USD | 227.788% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -10858.607% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 66.118% |
| Surrozen, Inc. | -27.23 Million USD | 296.394% |
| Generation Bio Co. | -73.91 Million USD | 172.355% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 168.917% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 12337.529% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 214.174% |
| Invivyd, Inc. | -2.02 Million USD | 2736.982% |
| Cingulate Inc. | -582.91 Thousand USD | 9274.189% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 117.776% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 51800.536% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 706546.499% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 44.506% |
| Jaguar Health, Inc. | 7.72 Million USD | -592.361% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 45.591% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -579.431% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 6170.148% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 92.144% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -121.816% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 27621.151% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 1.37 Million USD | -3797.813% |
| Innoviva, Inc. | 261.06 Million USD | 79.515% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 199.65% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -83.59% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 6496.89% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 35.889% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -73045.311% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -0.594% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 130.879% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 15249.575% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 172609.677% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 371.476% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 5512.753% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 95016.758% |
| AlloVir, Inc. | -398 Thousand USD | 13536.683% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 5281.977% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 82.951% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 18414.384% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 8153.916% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -1232.619% |
| ImmunityBio, Inc. | -17.89 Million USD | 398.927% |
| Korro Bio, Inc. | -3.63 Million USD | 1573.223% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 155.16% |
| Kineta, Inc. | 5.43 Million USD | -884.318% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 30686.297% |
| BioVie Inc. | -229.37 Thousand USD | 23414.456% |
| Codexis, Inc. | 57.33 Million USD | 6.726% |
| Celularity Inc. | 6.75 Million USD | -691.68% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 14398.93% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -105608.638% |
| Kodiak Sciences Inc. | -25.94 Million USD | 306.105% |
| Cibus, Inc. | 1.42 Million USD | -3660.759% |
| Annexon, Inc. | -3.26 Million USD | 1736.915% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 228.131% |
| Moderna, Inc. | 2.15 Billion USD | 97.518% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 93.131% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 2716.341% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -8255.938% |
| Immix Biopharma, Inc. | -5468.00 USD | 978117.557% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 69.08% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 959.499% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 48.628% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 2914.632% |
| Alkermes plc | 1.37 Billion USD | 96.11% |
| Arcellx, Inc. | 108.27 Million USD | 50.611% |
| Moolec Science SA | -143.3 Thousand USD | 37417.609% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 265.214% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -1526.955% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 32.481% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 352.827% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 176.299% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 2929.524% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 1480664.784% |
| Humacyte, Inc. | -76.55 Million USD | 169.86% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 226.372% |
| Geron Corporation | -123.5 Million USD | 143.301% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -1121.517% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 1.79 Billion USD | 97.019% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -23011.53% |
| Notable Labs, Ltd. | 113 Thousand USD | -47225.664% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 147.999% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 5734.162% |
| IN8bio, Inc. | -2.5 Million USD | 2238.265% |
| 89bio, Inc. | -273 Thousand USD | 19689.011% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 178360.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -2772.073% |
| Acasti Pharma Inc. | -11 Thousand USD | 486263.636% |
| Genelux Corporation | -848 Thousand USD | 6406.368% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 43578.049% |
| Liquidia Corporation | 14.6 Million USD | -266.288% |
| Mustang Bio, Inc. | -2.22 Million USD | 2503.506% |
| Immunovant, Inc. | -231 Thousand USD | 23250.649% |
| Vericel Corporation | 135.57 Million USD | 60.555% |
| Quantum-Si incorporated | 488 Thousand USD | -10858.607% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 196.254% |
| XOMA Corporation | 3.86 Million USD | -1285.082% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 366.91% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 26235.658% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 8347.0% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 5079.33% |
| Vaxcyte, Inc. | -75 Million USD | 171.304% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 131.925% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 14136.22% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 343.226% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 21.501% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 2831.256% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 6504.551% |
| PepGen Inc. | -1.18 Million USD | 4616.723% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 42208.661% |
| United Therapeutics Corporation | 2.07 Billion USD | 97.417% |
| Solid Biosciences Inc. | -76.56 Million USD | 169.848% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 64856.669% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Immuneering Corporation | -764.13 Thousand USD | 7098.474% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -80604.455% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 1456.604% |
| Belite Bio, Inc | -399 Thousand USD | 13503.008% |
| Pharming Group N.V. | 220.1 Million USD | 75.703% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | -434.44 Thousand USD | 12409.385% |
| Pyxis Oncology, Inc. | -2 Million USD | 2773.9% |
| uniQure N.V. | 2.21 Million USD | -2314.357% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 65317.073% |
| GeoVax Labs, Inc. | -20.72 Million USD | 358.089% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 158.085% |
| Altimmune, Inc. | -65.37 Million USD | 181.804% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 5079.33% |
| Peak Bio, Inc. | 367.76 Thousand USD | -14441.193% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 12337.529% |
| Benitec Biopharma Inc. | 108 Thousand USD | -49416.667% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 85.228% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 532166.461% |
| Compugen Ltd. | 31.45 Million USD | -70.014% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -4613.462% |
| argenx SE | 1.1 Billion USD | 95.176% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -118.135% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 333.559% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 68661.538% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 4545.387% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 10247.628% |
| PolyPid Ltd. | -1.82 Million USD | 3035.126% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 45039.496% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 1219.489% |
| Forte Biosciences, Inc. | -9000.00 USD | 594300.0% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -2064.225% |
| Instil Bio, Inc. | -4.75 Million USD | 1224.432% |
| Elevation Oncology, Inc. | -39 Thousand USD | 137223.077% |
| Immunome, Inc. | -8.9 Million USD | 700.404% |
| Verona Pharma plc | -679.62 Thousand USD | 7968.763% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 13206.389% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 30658.857% |
| Shattuck Labs, Inc. | -2.38 Million USD | 2342.264% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 2321.77% |
| Design Therapeutics, Inc. | -537 Thousand USD | 10058.659% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 12624.122% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -2391.985% |
| Achilles Therapeutics plc | -4.73 Million USD | 1230.31% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -124267.442% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 6605.839% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 406529.549% |
| Beam Therapeutics Inc. | -59.67 Million USD | 189.62% |
| Moolec Science SA | -143.3 Thousand USD | 37417.609% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 1069660.0% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -148.215% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 18106.061% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 659.042% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -279.815% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 2101.776% |
| Athira Pharma, Inc. | -969 Thousand USD | 5618.885% |
| HCW Biologics Inc. | -574.82 Thousand USD | 9403.369% |
| XOMA Corporation | 3.86 Million USD | -1285.082% |
| NeurAxis, Inc. | 2.15 Million USD | -2379.617% |
| Lumos Pharma, Inc. | 2 Million USD | -2564.574% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 30658.857% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 50706.104% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 4545.387% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -68.92% |
| Arvinas, Inc. | 71.8 Million USD | 25.518% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Palisade Bio, Inc. | 246 Thousand USD | -21639.024% |
| Nutriband Inc. | 862.1 Thousand USD | -6103.189% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 217.41% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 162154.545% |
| Merus N.V. | -83.46 Million USD | 164.075% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 185.19% |
| Neurogene Inc. | -3.26 Million USD | 1739.424% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 61.619% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 97332.727% |
| CervoMed Inc. | -1.29 Million USD | 4233.958% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 1548.483% |
| Sesen Bio, Inc. | 40 Million USD | -33.695% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 16708.075% |
| Rezolute, Inc. | -36 Thousand USD | 148650.0% |
| Clene Inc. | 533 Thousand USD | -9933.396% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 4165053.271% |
| BeyondSpring Inc. | 1.75 Million USD | -2954.14% |
| Synlogic, Inc. | -1.92 Million USD | 2879.522% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 144635.135% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 944.567% |
| Peak Bio, Inc. | 367.76 Thousand USD | -14441.193% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 382.012% |
| Krystal Biotech, Inc. | 47.6 Million USD | -12.337% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 62.097% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -964.239% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 2165.41% |
| MannKind Corporation | 136.19 Million USD | 60.733% |
| Ikena Oncology, Inc. | -50.49 Million USD | 205.914% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 50.854% |
| Gossamer Bio, Inc. | -4.38 Million USD | 1319.567% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 21321.429% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1069660.0% |
| Legend Biotech Corporation | 140.92 Million USD | 62.053% |
| Mural Oncology plc | -2.56 Million USD | 2183.288% |
| Disc Medicine, Inc. | -100 Thousand USD | 53578.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -157.676% |
| REGENXBIO Inc. | 53.02 Million USD | -0.847% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 1098.291% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 27898.83% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 3187.644% |
| Vaxart, Inc. | -60.76 Million USD | 188.011% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 20450.864% |
| Cellectis S.A. | 18 Thousand USD | -297000.0% |
| Longeveron Inc. | 221 Thousand USD | -24098.19% |
| Repare Therapeutics Inc. | -80.07 Million USD | 166.789% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 95.107% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 4232.767% |
| Revolution Medicines, Inc. | -399.66 Million USD | 113.381% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 152894.286% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -109038.776% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 99.379% |
| Denali Therapeutics Inc. | -93.34 Million USD | 157.291% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 213593.553% |
| Veru Inc. | 7.56 Million USD | -606.827% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 35515.894% |
| Cingulate Inc. | -582.91 Thousand USD | 9274.189% |
| Passage Bio, Inc. | -3.72 Million USD | 1537.194% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 444121.92% |
| Exicure, Inc. | -1.42 Million USD | 3858.117% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 14062.924% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -1878.468% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 10531.17% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 35845.654% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 190.325% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -13577.238% |
| OmniAb, Inc. | 14.66 Million USD | -264.614% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -167.484% |
| Lipocine Inc. | -2.85 Million USD | 1975.883% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 3001.682% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 1037.388% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 3650.31% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 28.995% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 82373.846% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 36.559% |
| Ocugen, Inc. | -33.53 Million USD | 259.46% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 1791.271% |
| Q32 Bio Inc. | 578 Thousand USD | -9152.249% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 20280.377% |
| Alumis Inc. Common Stock | -1.28 Million USD | 4264.953% |
| Equillium, Inc. | 35.95 Million USD | -48.724% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 3232.865% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -10581.095% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 1293713.933% |
| Dominari Holdings Inc. | 2.03 Million USD | -2522.756% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 29247.931% |
| vTv Therapeutics Inc. | -13.59 Million USD | 493.365% |
| Bio-Techne Corporation | 773.07 Million USD | 93.082% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -208.782% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 88.394% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 4674.679% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 323.011% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -357.194% |
| Nkarta, Inc. | -5.86 Million USD | 1011.194% |
| BioCardia, Inc. | -7.24 Million USD | 837.729% |
| Iterum Therapeutics plc | -1.75 Million USD | 3155.886% |